Biotechnology Investment Today Company Profile

18:58 EDT 18th March 2018 | BioPortfolio

Biotechnology Investment Today Biotechnology Investment Today (B.I.T.) provides industry stakeholders, both scientists and financers, with original and relevant data, information and knowledge on all aspects of the biotechnology industry. To this end, the company has developed a highly respected product portfolio, comprising its magazine, which reaches over 80,000 readers annually, its series of BioBusiness seminars and its website.

The B.I.T. magazine reaches a global audience of senior decision-makers and provides them with thought-provoking, timely and qualitative insights to critical industry issues. The content originates from industry leaders, government policy makers, market makers and analysts. It is our mission to serve the growing need for constantly updated information by Biotech CEOs and those in equivalent positions, institutional investors and venture capitalists eager to identify new and exciting business opportunities.

The renowned and highly acclaimed BioBusiness Seminar Series ensure that B.I.T. continue to maintain and further develop close relationships with the principal stakeholders in the industry. The seminars enable investors to immerse themselves in an environment which encourages, and is conducive to senior management meetings. The relaxed format allows questions to be openly asked and the conclusions drawn on company potential facilitate real business development.

Our website enables users to locate information regarding new scientific and financial developments quickly and easily providing them with an invaluable aid in identifying new investment opportunities. Our mission is to help companies by


60 Wharf Road
N1 7SF
United Kingdom


Phone: 44 (0)20 7253 5440
Fax: 44 (0)20 7253 9543

News Articles [1344 Associated News Articles listed on BioPortfolio]

Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel

Merck, a leading science and technology company, today announced ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in ...

Pfizer’s Investment Strategy

Pfizer recognises the importance of biotechnology and the need for good science. Barbara Dalton and Daniel Grant explain their different roles in Pfizer and the ways in which the company can invest to...

BIOTECanada Welcomes Federal Government’s $400 Million Commitment to Venture Capital Catalyst Initiative

BIOTECanada welcomes today’s announcement by the federal government to commit $400 million to the federal Venture Capital Catalyst Initiative (VCCI). The VCCI’s predecessor, ...

Merck partners on 20 million-euro pre-seed investment initiative in Israel

Merck KGaA today announced the creation of ExploreBio, a pre-seed-investment vehicle by four investment…

GroupM: Global Ad Investment Will Grow 4. ...

NEW YORK, Dec. 4, 2017/PRNewswire/ -- GroupM, the media investment group of WPP, today updated its ad investment forecasts for 2017 and Read more...

Industry report calls for greater investment in pain and addiction therapies

A new report from US-based Biotechnology Innovation Organization (BIO) advocates greater levels of investment…

Clal Biotechnology Industries (CBI) - Israeli science, worldwide presence

Edison Investment Research - Pharmaceutical & healthcare - Clal Biotechnology Industries: We are initiating coverage on Clal Biotechnology Industries (CBI), an Israel/Boston-based healthcare investmen...

Stock Review for REIT's Investors -- Granite Point Mortgage Trust, New Residential Investment, ... strives to bring the best free research to the investment community.  Today we are offering reports on GPMT, NRZ, TWO, and UDR which can Read more...

Drugs and Medications [43 Associated Drugs and Medications listed on BioPortfolio]

Act restoring anticavity fluoride cool splash mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Mint

Act restoring anticavity fluoride cool splash mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Mint 2x

Act restoring anticavity fluoride cool splash spearmint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Spearmint

Act restoring anticavity fluoride mouthwash cool splash spearmint 2x [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Spearmint 2X

Act restoring anticavity fluoride cool splash vanilla mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Vanilla Mint

PubMed Articles [676 Associated PubMed Articles listed on BioPortfolio]

Enhanced Recovery After Surgery Implementation: from Planning to Success.

Enhanced recovery after surgery (ERAS(®)) is an evidence-based approach in perioperative care. The implementation and translation of ERAS pathways into clinical practice requires a certain investment...

Next generation industrial biotechnology based on extremophilic bacteria.

Industrial biotechnology aims to produce bulk chemicals including polymeric materials and biofuels based on bioprocessing sustainable agriculture products such as starch, fatty acids and/or cellulose....

'Bioexit': navigating the policy and regulatory pathways for the biotechnology industry in a post-Brexit landscape.

The withdrawal of the UK from the European Union (EU) is a complicated event. Although implications vary by industry, the biotechnology sector is especially vulnerable to the consequences of Brexit. A...

Better Open Than Intellectual: The Benefits of Investment Personality Traits for Learning.

The investment theory of adult intelligence posits that individual differences in knowledge attainment result from people's differences in cognitive ability and their propensity to apply and invest th...

Social Return on Investment: A New Approach to Understanding and Advocating for Value in Healthcare.

To determine whether the methodology of social return on investment (SROI) could be a way in which the value of a healthcare-related program (children's cancer camp) could be captured, evaluated, and ...

Clinical Trials [346 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Determine Return on Investment in Heart Failure Remote Monitoring Program

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return ...

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has sponsored a consortium of investigators to conduct a clinical tr...

Mother-Child Relationships During Pregnancy Among Bofi Foragers

This study will examine changes in mother-child relationships when mothers are pregnant, because this period may involve conflicts between mothers and children. A widely held evolutionary...

Taking on Diabetes to Advance You (TODAY)

The program will consist of diabetes self-management sessions, led by an occupational therapist. The sessions will be held in a group education format. Sessions will focus on diabetes educ...

Companies [2482 Associated Companies listed on BioPortfolio]

Biotechnology Investment Today

Biotechnology Investment Today Biotechnology Investment Today (B.I.T.) provides industry stakeholders, both scientists and financers, with original and relevant data, information and knowledge on all ...

European partnering & Invest Conference

EPIC is a biotechnology conference which showcases over 60 UK and European biotechnology companies. It is the perfect opportunity to hear from and meet a range of growing biotechnology companies who n...


Mulligan Biocapital AG is an investment firm dedicated to the life sciences with a specific focus on biotechlology with healt care applications.We invest in North Amercn and european biotechnology ven...

venBio Select Advisor LLC

venBio Select Advisor LLC (“venBio Select”) is the SEC registered investment manager for venBio’s public markets strategy and its main equity investment vehicle â...

China Development Financial Holding Corporation

CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan’s...

More Information about "Biotechnology Investment Today" on BioPortfolio

We have published hundreds of Biotechnology Investment Today news stories on BioPortfolio along with dozens of Biotechnology Investment Today Clinical Trials and PubMed Articles about Biotechnology Investment Today for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotechnology Investment Today Companies in our database. You can also find out about relevant Biotechnology Investment Today Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record